Orforglipron (Oral Small Molecule GLP-1)
$220.00Orforglipron is Eli Lilly's groundbreaking non-peptide oral GLP-1 capsule that can be taken at any time of day with or without food and water restrictions.
Available: 12mg, 24mg, 36mg, 45mg
In Stock (65 available)
Why Choose Orforglipron?
No food or water restrictions! Unlike first-gen oral peptides, Orforglipron absorbs effortlessly without strict morning fasting rules.
How to Use
Swallow one capsule daily with water at any convenient time of day.
Safety Information
Follow titration from 12mg upwards to minimize gastrointestinal adaptation effects.
Potential Side Effects
Mild nausea, reduced appetite, and mild constipation during dosage changes.
Product Facts
| Generic Name | Orforglipron (LY3502970) |
| Brand Name | Orforglipron |
| Type of Medication | Non-Peptide Oral GLP-1 Receptor Agonist |
| FDA Approval Date | August 1, 2024 |
| Indications | High-potency small-molecule oral GLP-1 agonist for daily weight reduction without food/water timing constraints. |
| Dosage Forms | Oral capsules (12 mg, 24 mg, 36 mg, 45 mg) |
| Administration | Once daily with water at any time of day |
| Special Precautions | Convenient non-peptide formulation with high oral bioavailability independent of stomach pH. |
| Drug Interactions | Standard GLP-1 class profile; mild transient GI adaptation. |
| Use in Specific Populations | Not recommended in pregnancy or lactation. |
| Prescription | Prescription Required |
| Manufacturer | Eli Lilly and Company |
How to Buy
Choose your month titration capsule strength and order online discreetly.